Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial
Authors
Guang Han (ORCID: https://orcid.org/0000-0001-5500-3338)
Zirui Ke
Guoliang Pi (ORCID: https://orcid.org/0000-0002-2740-2857)
Caixun Zhang
Hanguang Ruan
Ying Li (ORCID: https://orcid.org/0000-0003-4148-0154)
Beijing Xisike Clinical Oncology Research Foundation
Chinese Society of Clinical Oncology
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial
Guang Han, Zirui Ke, Guoliang Pi, Caixun Zhang et al.
Journal
BMJ Open
Topics
Lung Cancer Diagnosis and Treatment
article
Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial
Guang Han, Zirui Ke, Guoliang Pi, Caixun Zhang, Hanguang Ruan, Ying Li, Zilong Yuan, Yujie Huang, Jun Shao, Jianping Bi
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(9)
Institutions
Jiangxi Provincial Cancer Hospital (CN), Hubei Cancer Hospital (CN), Huazhong University of Science and Technology (CN)
Funders
Beijing Xisike Clinical Oncology Research Foundation, Chinese Society of Clinical Oncology